4P-Pharma team will be attending the next BioFIT 2016 conference in Lille, France, on November 30- December 1st. Come and meet us Booth I11 to talk about innovation, maturation program and co-development partnership! You can also schedule a meeting with via the partnering platform. We hope to meet you there!
4P-Pharma announces the entry into its capital of M comme Mutuelle. Lille, September 19 4P-Pharma, a biotechnology company specializing in the development of new medicines in the areas of cancer, inflammatory diseases, and stimulants abuse, announces the entry into its capital of M comme Mutuelle. This new funding will help support the first phase I&hellip
Signature of a license agreement between 4P-Pharma, SATT-Aquitaine and University of Bordeaux for the development of an anti-cancer drug. Talence, September 1st 4P-Pharma has signed an exclusive license agreement with Aquitaine Science Transfert, for the development of a drug targeting pancreatic cancer, triple negative breast cancer or colon cancer. The molecule was first developed&hellip
Today, we are celebrating our 2nd anniversary! We would like to thank our partners for their trust along those two years, and hope to welcome even more collaborators in the years to come!
4P-Pharma team will participate to the annual La Parisienne race on September 11, 2016. La Parisienne is an annual race occurring in Paris. Each year, some of the benefits of the race are used to raise awareness and support medical research against breast cancer.
MATWIN and Cancer Campus are organizing a workshop whose theme will be ” How to optimize and maturate innovations in the field of oncology: from preclinical to early clinical trials” . The workshop will be held in Paris, september 8-9. Our CEO, Revital Rattenbach will be giving a presentation on september 8 2016. She will&hellip